University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Hookah and Cigarette Smoking

Phase 1

Completed

Conditions: Smoking

Interventions: Drug: Cigarette
Drug: Hookah

First Posted Date: 2009-10-09

Last Posted Date: 2013-05-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 13

Registration Number: NCT00992550

Locations: 🇺🇸
San Francisco General Hospital-CTSI CRC, San Francisco, California, United States

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women

Phase 3

Completed

Conditions: Malaria
HIV Infections

Interventions: Drug: Lopinavir/ritonavir
Drug: Efavirenz
Drug: Zidovudine
Drug: Lamivudine

First Posted Date: 2009-10-09

Last Posted Date: 2019-05-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 389

Registration Number: NCT00993031

Locations: 🇺🇬
Tororo District Hospital, Tororo, Uganda

Atherosclerosis in Rheumatoid Arthritis

Completed

Conditions: Endothelial Dysfunction
Rheumatoid Arthritis

First Posted Date: 2009-10-07

Last Posted Date: 2012-01-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT00990730

Locations: 🇺🇸
UCSF San Francisco General Hospital Vascular Research Center, San Francisco, California, United States

Comparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of Psoriasis

Phase 4

Completed

Conditions: Stable Plaque Psoriasis

Interventions: Drug: Ultravate ointment twice daily + LacHydrin lotion twice daily
Drug: Ultravate ointment once daily + LacHydrin lotion twice daily

First Posted Date: 2009-10-07

Last Posted Date: 2019-01-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT00990561

Locations: 🇺🇸
UCSF Psoriasis and Skin Treatment Center, San Francisco, California, United States

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Phase 3

Terminated

Conditions: Ischemic Attack, Transient

Interventions: Drug: placebo
Drug: Clopidogrel

First Posted Date: 2009-10-07

Last Posted Date: 2018-12-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 4881

Registration Number: NCT00991029

Locations: 🇺🇸
Chandler Regional Medical Center, Chandler, Arizona, United States
🇺🇸
Banner University Medical Center - Tucson Campus, Tucson, Arizona, United States
🇺🇸
George Washington University Hospital, Washington, District of Columbia, United States

and more 206 locations

Improving Antibiotic Prescribing Practices in Mexican Primary Care Clinics

Not Applicable

Completed

Conditions: Acute Respiratory Tract Infections

Interventions: Behavioral: Computer kiosk Education

First Posted Date: 2009-10-05

Last Posted Date: 2011-05-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 847

Registration Number: NCT00989482

Locations: 🇲🇽
IMSS Family Practice Clinic #1, Cuernavaca, Morelos, Mexico

The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems

Phase 4

Completed

Conditions: Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
Parkinsons Disease With Dementia

Interventions: Drug: Rivastigmine Patch 9.5 cm2

First Posted Date: 2009-10-01

Last Posted Date: 2014-02-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 15

Registration Number: NCT00988117

Locations: 🇺🇸
UCalifornia SF, San Francisco, California, United States

Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma

Phase 1

Terminated

Conditions: Multiple Myeloma
Patient Participation

Interventions: Drug: Doxil, melphalan, bortezomib

First Posted Date: 2009-09-29

Last Posted Date: 2020-06-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 13

Registration Number: NCT00985907

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
St. Vincent's Comprehensive Cancer Center, New York, New York, United States

Yoga Breathing for Fatigue in Patients Undergoing Chemotherapy

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Pranayama (Yoga Breathing) Techniques

First Posted Date: 2009-09-23

Last Posted Date: 2011-08-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 25

Registration Number: NCT00982748

Locations: 🇺🇸
Osher Center for Integrative Medicine, UCSF, San Francisco, California, United States

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Phase 3

Completed

Conditions: Malaria
HIV Infections

Interventions: Drug: Lopinavir/Ritonavir (LPV/r)
Drug: Nevirapine (NVP)
Drug: Efavirenz (EFV)
Drug: 2 nucleoside reverse transcriptase inhibitor (NRTI)

First Posted Date: 2009-09-16

Last Posted Date: 2018-12-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 176

Registration Number: NCT00978068

Locations: 🇺🇬
IDRC - Tororo Research Clinic, Tororo, Uganda

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy